The chemical substance with the name "(1S,2R,3S,4S,6S)-8-[3-Oxatricyclo[3.2.1.0(2,4)]oct-6-yl]-1,3-dipropylxanthine" and CAS number "166374-49-8" is a xanthine derivative, which is a class of compounds known for their role as stimulants and their involvement in various biological processes. This particular compound features a complex bicyclic structure that includes a xanthine core, characterized by its nitrogen-containing heterocyclic ring system. The presence of the dipropyl groups enhances its lipophilicity, potentially influencing its pharmacokinetic properties. The stereochemistry indicated by the (1S,2R,3S,4S,6S) configuration suggests specific spatial arrangements of atoms that may affect the compound's interaction with biological targets, such as receptors or enzymes. This compound may exhibit biological activity, possibly as an antagonist or modulator of adenosine receptors, which are implicated in numerous physiological functions, including neurotransmission and cardiovascular regulation. Further studies would be necessary to elucidate its specific pharmacological effects and potential therapeutic applications.

(1S,2R,3S,4S,6S)-8-[3-Oxatricyclo[3.2.1.0(2,4)]oct-6-yl]-1,3-dipropylxanthine

166374-49-8: The chemical substance with the name "(1S,2R,3S,4S,6S)-8-[3-Oxatricyclo[3.2.1.0(2,4)]oct-6-yl]-1,3-dipropylxanthine" and CAS number "166374-49-8" is a xanthine derivative, which is a class of compounds known for their role as stimulants and their involvement in various biological processes. This particular compound features a complex bicyclic structure that includes a xanthine core, characterized by its nitrogen-containing heterocyclic ring system. The presence of the dipropyl groups enhances its lipophilicity, potentially influencing its pharmacokinetic properties. The stereochemistry indicated by the (1S,2R,3S,4S,6S) configuration suggests specific spatial arrangements of atoms that may affect the compound's interaction with biological targets, such as receptors or enzymes. This compound may exhibit biological activity, possibly as an antagonist or modulator of adenosine receptors, which are implicated in numerous physiological functions, including neurotransmission and cardiovascular regulation. Further studies would be necessary to elucidate its specific pharmacological effects and potential therapeutic applications.

Naxifylline is an A1 adenosine receptor blocker that increases urine and protects kidneys during edema treatment in heart failure.

CAS 166374-49-8

(1S,2R,3S,4S,6S)-8-[3-Oxatricyclo[3.2.1.0(2,4)]oct-6-yl]-1,3-dipropylxanthine

Naxifylline

Ref: TM-T33600